The serum level of FADS2 was detected by enzyme-linked immunosorbent assay (ELISA) in healthy people, NAFLD patients, and NAFLD patients combined with CAD (NAFLD+CAD). The gene discussed is FADS2; the disease is metabolic dysfunction-associated steatotic liver disease.